|
74
|
285
|
9fwuB |
Crystal structure of sars-cov-2 nsp10-nsp14 (exon) in complex with vt00421 |
|
36
|
131
|
9fwtA |
Ensemble model of ligand-free sars-cov-2 nsp10-nsp14 (exon) and in complex with partially bound vt00259 |
|
36
|
131
|
9fwmA |
Crystal structure of sars-cov-2 nsp10-nsp14 (exon) in complex with vt00180 |
|
36
|
131
|
9fwjA |
Ensemble model of ligand-free sars-cov-2 nsp10-nsp14 (exon) and in complex with partially bound vt00079 |
|
30
|
258
|
9eaaA |
Seneca valley virus altered particle at acidic condition (a-particle[c]) |
|
20
|
238
|
9eadB |
Seneca valley virus empty rotated particle at physiological condition (er-particle[p]) |
|
25
|
238
|
9eabB |
Seneca valley virus altered particle at physiological condition (a-particle[p]) |
|
1
|
58
|
9eaaD |
Seneca valley virus altered particle at acidic condition (a-particle[c]) |
|
19
|
230
|
9eacA |
Seneca valley virus empty rotated particle at acidic condition (er-particle[c]) |
|
24
|
238
|
9eacB |
Seneca valley virus empty rotated particle at acidic condition (er-particle[c]) |
|
24
|
218
|
9eadC |
Seneca valley virus empty rotated particle at physiological condition (er-particle[p]) |
|
37
|
268
|
9eaaC |
Seneca valley virus altered particle at acidic condition (a-particle[c]) |
|
0
|
58
|
9eabD |
Seneca valley virus altered particle at physiological condition (a-particle[p]) |
|
16
|
231
|
9eadA |
Seneca valley virus empty rotated particle at physiological condition (er-particle[p]) |
|
31
|
267
|
9eabC |
Seneca valley virus altered particle at physiological condition (a-particle[p]) |
|
23
|
258
|
9eabA |
Seneca valley virus altered particle at physiological condition (a-particle[p]) |
|
22
|
238
|
9eaaB |
Seneca valley virus altered particle at acidic condition (a-particle[c]) |
|
30
|
217
|
9eacC |
Seneca valley virus empty rotated particle at acidic condition (er-particle[c]) |
|
96
|
308
|
9e7kA |
Crystal structure of the uch37 rpn13 deubad complex bound to an inhibitory nanobody in the canonical ubiquitin binding site |
|
81
|
711
|
9di2B |
Cryo-em structure of the usp1-uaf1-ubiquitin-vs complex |
|
91
|
702
|
9di1B |
Cryo-em structure of the usp1-uaf1-ubiquitin complex inhibited by ksq-4279 |
|
88
|
301
|
9ddfA |
Sars-cov-2 main protease with inhibitor |
|
89
|
302
|
9ddgA |
Sars-cov-2 main protease with inhibitor |
|
86
|
301
|
9cjuA |
Structure of sars-cov-2 main protease in complex with bofutrelvir in orthorhombic form |
|
83
|
301
|
9cjtA |
X-ray crystal structure of sars-cov-2 main protease quadruple mutants in complex with bofutrelvir |
|
83
|
303
|
9cjvA |
X-ray crystal structure of sars-cov-2 main protease complex with bofutrelvir |
|
83
|
303
|
9cjpA |
X-ray crystal structure of sars-cov-2 main protease quadruple mutants in complex with nirmatrelvir |
|
83
|
301
|
9cjsA |
X-ray crystal structure of sars-cov-2 main protease triple mutants in complex with bofutrelvir |
|
64
|
288
|
9cgcV |
Yeast 26s proteasome non-substrate-engaged (s1 state) |
|
76
|
301
|
9cjoA |
X-ray crystal structure of sars-cov-2 main protease quadruple mutants |
|
84
|
305
|
9cjqA |
X-ray crystal structure of sars-cov-2 main protease quadruple mutants in complex with ensitrelvir |
|
86
|
300
|
9cjrA |
X-ray crystal structure of sars-cov-2 main protease double mutants in complex with ensitrelvir |
|
96
|
315
|
9bf7A |
Sars-cov-2 papain-like protease (plpro) c111s untagged crystal structure |
|
93
|
315
|
8xtdA |
Sars-cov-2 papain-like-protease (plpro) in complex with inhibitor linagliptin |
|
66
|
167
|
7ijhA |
Pandda analysis group deposition -- crystal structure of sars-cov-2 nsp3 macrodomain in complex with z8990523176 |
|
64
|
166
|
7ijoA |
Group deposition of sars-cov-2 nsp3 macrodomain in complex with inhibitors from the o'brien group -- crystal structure of sars-cov-2 nsp3 macrodomain in complex with pob177 (mac1-x10183) |
|
66
|
167
|
7iiyA |
Pandda analysis group deposition -- crystal structure of sars-cov-2 nsp3 macrodomain in complex with z8598075283 |
|
65
|
167
|
7hhuA |
Pandda analysis group deposition -- crystal structure of sars-cov-2 nsp3 macrodomain in complex with avi-0000528 |
|
62
|
165
|
7ijqA |
Group deposition of sars-cov-2 nsp3 macrodomain in complex with inhibitors from the o'brien group -- crystal structure of sars-cov-2 nsp3 macrodomain in complex with pob176 (mac1-x10199) |
|
67
|
167
|
7iixA |
Pandda analysis group deposition -- crystal structure of sars-cov-2 nsp3 macrodomain in complex with z7691912366 |
|
64
|
167
|
7hhxA |
Pandda analysis group deposition -- crystal structure of sars-cov-2 nsp3 macrodomain in complex with avi-0000729 |
|
65
|
167
|
7ij3A |
Pandda analysis group deposition -- crystal structure of sars-cov-2 nsp3 macrodomain in complex with z8727396582 |
|
63
|
165
|
7ik6A |
Group deposition of sars-cov-2 nsp3 macrodomain in complex with inhibitors from the o'brien group -- crystal structure of sars-cov-2 nsp3 macrodomain in complex with pob0217 (mac1-x10585) |
|
63
|
165
|
7ijnA |
Group deposition of sars-cov-2 nsp3 macrodomain in complex with inhibitors from the o'brien group -- crystal structure of sars-cov-2 nsp3 macrodomain in complex with pob175 (mac1-x10181) |
|
65
|
167
|
7ijiA |
Pandda analysis group deposition -- crystal structure of sars-cov-2 nsp3 macrodomain in complex with z8990523172 |
|
67
|
167
|
7hprA |
Pandda analysis group deposition -- crystal structure of sars-cov-2 nsp3 macrodomain in complex with cache3hi_1696_50 |
|
63
|
167
|
7ijmA |
Pandda analysis group deposition -- crystal structure of sars-cov-2 nsp3 macrodomain in complex with z7534253453 |
|
62
|
166
|
7ijuA |
Group deposition of sars-cov-2 nsp3 macrodomain in complex with inhibitors from the o'brien group -- crystal structure of sars-cov-2 nsp3 macrodomain in complex with pob0206 (mac1-x10390) |
|
66
|
167
|
7ijgA |
Pandda analysis group deposition -- crystal structure of sars-cov-2 nsp3 macrodomain in complex with z8990527720 |
|
63
|
166
|
7ijxA |
Group deposition of sars-cov-2 nsp3 macrodomain in complex with inhibitors from the o'brien group -- crystal structure of sars-cov-2 nsp3 macrodomain in complex with pob0209 (mac1-x10400) |
